tiprankstipranks
Advertisement

GSEU - ETF AI Analysis

Compare

Top Page

GSEU

Goldman Sachs ActiveBeta Europe Equity ETF (GSEU)

Rating:63Neutral
Price Target:
GSEU, the Goldman Sachs ActiveBeta Europe Equity ETF, has a solid overall rating driven mainly by high-quality European leaders like Novartis, AstraZeneca, and HSBC, which show strong financial performance, positive earnings outlooks, and generally supportive technical trends. Defensive giants such as Nestlé and Roche add stability, though some holdings like Shell, Allianz, and SAP face issues such as weaker momentum, growth challenges, or valuation concerns that slightly weigh on the fund. The main risk factor is its concentration in large European companies and sectors like healthcare and financials, which can make performance sensitive to regional economic and regulatory conditions.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past month, indicating positive recent momentum.
Leading European Blue-Chip Holdings
Top positions include several well-known European companies that have delivered generally strong or steady performance, helping support the fund’s returns.
Moderate Expense Ratio
The fund’s fee is relatively low for an actively managed European equity strategy, allowing investors to keep more of their returns.
Negative Factors
Country Concentration in a Few Markets
A large share of assets is focused in the UK, France, Germany, and Switzerland, which increases sensitivity to economic or political issues in those countries.
Mixed Performance Among Top Holdings
A few of the largest positions have shown weak or negative performance this year, which can drag on overall fund results.
Limited Exposure to Growth Sectors
The portfolio has relatively small weights in technology and communication services, which may limit participation in faster-growing parts of the market.

GSEU vs. SPDR S&P 500 ETF (SPY)

GSEU Summary

GSEU is the Goldman Sachs ActiveBeta Europe Equity ETF, which follows the Goldman Sachs ActiveBeta Europe Equity index. It invests in a wide range of European companies of different sizes and sectors, giving you broad exposure to the European stock market. Well-known holdings include ASML, Nestlé, HSBC, and Shell. An investor might choose this ETF to diversify beyond the U.S. and tap into long-term growth opportunities across Europe in a single fund. However, its value can go up and down with European stock markets and currency movements, so your investment may be volatile.
How much will it cost me?The Goldman Sachs ActiveBeta Europe Equity ETF (Ticker: GSEU) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed funds because it uses a systematic strategy to balance multiple factors, making it more efficient than many traditional active funds.
What would affect this ETF?The GSEU ETF, which focuses on European equities, could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and stable financial sector performance, given its significant exposure to these areas. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could negatively impact industrial and consumer sectors. Its diversified holdings across developed European markets provide some resilience against sector-specific risks.

GSEU Top 10 Holdings

GSEU’s story is all about Europe’s heavy hitters quietly pulling the fund forward. Chip giant ASML is doing the heavy lifting, with rising momentum that gives the portfolio a tech-powered engine despite tech being a small slice overall. Big banks like HSBC and Banco Santander are also climbing, adding a financial tailwind, while AstraZeneca keeps healthcare exposure steady. On the flip side, Nestlé has been losing a bit of fizz and Roche looks mixed, softening some of the gains. Overall, it’s a diversified, developed-Europe mix rather than a single-sector bet.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.53%$4.00M€477.33B106.32%
76
Outperform
Roche Holding AG1.94%$2.19M$327.04B22.13%
73
Outperform
Novartis AG1.89%$2.14MCHF207.57B22.14%
80
Outperform
HSBC Holdings1.81%$2.05M£226.99B58.35%
80
Outperform
AstraZeneca1.78%$2.01M$292.69B32.74%
80
Outperform
Shell (UK)1.42%$1.61M£184.86B32.32%
73
Outperform
Banco Santander1.34%$1.52M€149.64B62.09%
73
Outperform
Nestlé SA1.33%$1.51MCHF205.30B-1.29%
71
Outperform
Siemens1.20%$1.36M€185.31B21.53%
74
Outperform
Allianz1.12%$1.26M€146.93B7.31%
67
Neutral

GSEU Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
46.78
Negative
100DMA
46.62
Positive
200DMA
44.75
Positive
Market Momentum
MACD
0.29
Positive
RSI
45.64
Neutral
STOCH
5.19
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSEU, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 47.45, equal to the 50-day MA of 46.78, and equal to the 200-day MA of 44.75, indicating a neutral trend. The MACD of 0.29 indicates Positive momentum. The RSI at 45.64 is Neutral, neither overbought nor oversold. The STOCH value of 5.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GSEU.

GSEU Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$113.90M0.25%
63
Neutral
$30.12B0.06%
62
Neutral
$9.43B0.50%
63
Neutral
$751.83M0.45%
64
Neutral
$722.09M0.07%
63
Neutral
$115.02M0.09%
64
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
46.62
7.40
18.87%
VGK
Vanguard FTSE Europe ETF
EZU
iShares MSCI Eurozone ETF
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
SPEU
SPDR Portfolio Europe ETF
FLEE
Franklin FTSE Europe ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement